Section Arrow
CDT.NASDAQ
- CDT Equity Inc.
Quotes are at least 15-min delayed:2026/04/02 07:31 EDT
Pre Market
Last
 4.07
-1.03 (-20.20%)
Bid
4.04
Ask
4.4
High 4.43 
Low 3.92 
Volume 22.40K 
Regular Hours (Closed)
Last
 5.1
0 (0.00%)
Day High 
5.12 
Prev. Close
5.1 
1-M High
18.245 
Volume 
746.31K 
Bid
4.04
Ask
4.4
Day Low
4.4 
Open
5.03 
1-M Low
4.96 
Market Cap 
11.75M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.44 
20-SMA 12.65 
50-SMA 20.48 
52-W High 4,200 
52-W Low 4.96 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-397.65/--
Enterprise Value
11.85M
Balance Sheet
Book Value Per Share
24.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics6.38+4.83+311.61%-- 
Pre Market 5.5595 -0.8205 -12.86%
ELABPmgc Holdings Inc14+8.01+133.72%0PE
Pre Market 4.61 -9.39 -67.07%
IOBTIO Biotech0.0437-0.015-25.55%-- 
Pre Market 0.0396 -0.0041 -9.38%
APLSApellis Pharmaceuticals40.39+0.16+0.40%224.11PE
Pre Market 40.3377 -0.0523 -0.13%
GERNGeron Corp1.66+0.17+11.41%-- 
Pre Market 1.5762 -0.0838 -5.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved intoa broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.